However, molecular mechanisms underlying this increase in claudin-2 levels and its causal significance remain unclear especially considering the context-specific outcome from the murine models of IBD using mice genetically manipulated for claudin-2 expression17–19. This evidence concerns the gene CLDN2 and inflammatory bowel disease.